Form 4: BioCardia CEO Buys Shares
Insider Transaction (Form 4)
Peter Altman, President and CEO and a Director of BioCardia, Inc., purchased 500 shares of common stock on October 15, 2026 for $0.95 per share.
Summary
- Open-market purchase: acquired 200 Common Stock at $0.95 ($190) on October 15, 2026; holds 385,085 after (Direct).
- Open-market purchase: acquired 300 Common Stock at $0.95 ($285) on October 16, 2026; holds 385,385 after (Direct).
Sentiment
Score: 7
Explanation: StockSavvy.ai views this as a bullish signal: an insider made an open-market purchase of $475, committing personal capital to the stock.
Insider Transactions
Peter Altman — Director, Officer (President and CEO)
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-10-15 | Open-market purchase | Common Stock | 200 | $1 | $190 | 385,085 |
| 2026-10-16 | Open-market purchase | Common Stock | 300 | $1 | $285 | 385,385 |
Key Dates
| Date | Description |
|---|---|
| 2026-10-15 | Open-market purchase (200 shares) |
| 2026-10-16 | Open-market purchase (300 shares) |
Keywords
insider transaction, Form 4, BCDA, BioCardia, Inc., bullish, Peter Altman
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.